Tag: Cancer

  • Campus & Community

    Daffodil Days, Harvard collect record amount

    Consistently one of New England’s top sellers for the American Cancer Society’s annual Daffodil Days fundraiser, this year Harvard even managed to outdo itself. In this latest edition of the benefit, members of the University helped raise $45,843 to better every Harvard effort since the fundraiser’s inaugural run in 1988.

    1–2 minutes
  • Health

    Vitamin D may protect against prostate cancer

    With spring on the way, Harvard researchers advise men to get more sun, supplements, and seafood. All are good sources of vitamin D, and a large, lengthy study suggests the vitamin reduces risk of prostate cancer.

    3–4 minutes
  • Health

    Brugge, colleagues urge Senate to increase NIH funding

    Testifying Monday afternoon (March 19) before a U.S. Senate committee hearing on National Institutes of Health (NIH) funding, Harvard Medical School Cell Biology Department Chair Joan S. Brugge warned that “four years of flat [NIH] funding have had a devastating impact on the trajectory of cancer research,” threatening “the rapid progress in developing effective and…

    4–6 minutes
  • Health

    Study questions ‘cancer stem cell’ hypothesis in breast cancer growth

    A Dana-Farber Cancer Institute study challenges the hypothesis that “cancer stem cells” — a small number of self-renewing cells within a tumor — are responsible for breast cancer progression and recurrence, and that wiping out these cells alone could cure the disease.

    3–4 minutes
  • Health

    Common prostate cancer therapy may carry risks

    Androgen deprivation therapy – one of the most common treatments for prostate cancer – may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and other institutions.

    2–3 minutes
  • Campus & Community

    Daffodil orders taken through tomorrow

    Daffodil Days, one of the University’s most popular and colorful fundraisers, is accepting orders through Friday (March 2). Bouquets cost $7 each and include 10 stems. For $25, the bouquet includes a limited edition, collectible Boyds Bear teddy bear.

    1–2 minutes
  • Campus & Community

    Still time to order daffodils, help American Cancer Society

    Daffodil Days, one of the University’s most popular and colorful fundraisers, is now accepting orders from the Harvard community for the bright bouquets, which cost $7 each and include 10 stems. For $25, the bouquet includes a limited edition, collectible Boyds Bear teddy bear.

    1–2 minutes
  • Health

    Practical way to target cancer cell mutations demonstrated

    A study led by researchers at Dana-Farber Cancer Institute and Broad Institute of the Massachusetts Institute of Technology and Harvard University provides the first demonstration of a practical method of screening tumors for cancer-related gene abnormalities that might be treated with “targeted” drugs.

    3–5 minutes
  • Health

    Study: Heed spiritual needs of cancer patients

    People with advanced cancer felt they received little or no spiritual support from religious communities and the medical system, according to a new survey. However, those who did receive such support reported a better quality of life.

    3–4 minutes
  • Health

    Saving your self from yourself

    “Your gut is a complicated place,” notes Shannon Turley, an assistant professor of pathology at Harvard Medical School. In addition to processing food three or more times a day, an intestine needs to protect you from being damaged by yourself.

    4–6 minutes
  • Campus & Community

    Sengupta wins $4.1 million ‘Era of Hope’ award for breast cancer advances

    An assistant professor of medicine at Harvard has won a $4.1 million “Era of Hope” scholar award from the U.S. Defense Department’s Breast Cancer Research Program in support of his cutting-edge, interdisciplinary research aimed at fighting breast and other types of cancer.

    3–4 minutes
  • Campus & Community

    Popular hair-loss drug impedes prostate cancer detection in middle-aged men

    Researchers at Brigham and Women’s Hospital (BWH) have found that the prostate specific antigen (PSA) cancer screening test is falsely lowered by a factor of two in middle-aged men who…

    2–3 minutes
  • Campus & Community

    Risk of breast cancer may be associated with red meat consumption

    Researchers at Brigham and Women’s Hospital (BWH) have found that eating more red meat may be associated with a higher risk for hormone receptor–positive breast cancers in premenopausal women. This…

    1–2 minutes
  • Health

    Prostate treatment has risks

    A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20 Journal of Clinical Oncology. “Men with prostate cancer have high five-year survival rates, but they also have higher rates of noncancer mortality than healthy men,” says study author…

    2–3 minutes
  • Health

    New insight into skin-tanning process suggests novel way of preventing skin cancer

    Findings from a study led by researchers at Dana-Farber Cancer Institute and Children’s Hospital Boston have rewritten science’s understanding of the process of skin tanning – an insight that has…

    1–2 minutes
  • Health

    Prostate cancer treatment increases risk of diabetes, heart disease

    A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20, 2006, Journal of…

    2–3 minutes
  • Campus & Community

    Sunshine may help prevent breast cancer

    Evidence is piling up that boosting vitamin D intake may help prevent breast cancer. One major study of 1,760 women found that the higher the levels of vitamin D in…

    1–2 minutes
  • Health

    Advances in chemotherapy improve outcomes in select breast cancers

    Recent advances in chemotherapy have significantly reduced the risk of disease recurrence and death in breast cancer patients whose tumors are not hormone sensitive, according to a study by researchers…

    1–2 minutes
  • Health

    Scientists discover new genetic subtypes of common blood cancer

    Scientists at Dana-Farber Cancer Institute and collaborators have identified four distinct genetic subtypes of multiple myeloma, a deadly blood cancer, that have different prognoses and might be treated most effectively…

    1–2 minutes
  • Health

    Gene chips aid drug search in rare cancers

    When Kimberly Stegmaier was a pediatric oncology fellow at Dana-Farber and Children’s Hospital Boston six years ago, she says,”I was struck by how poorly our young patients with AML (acute…

    2–3 minutes
  • Arts & Culture

    Brigham pilot program connects people with family histories

    A Harvard Medical School instructor at Brigham and Women’s Hospital is spearheading a pilot project to encourage Brigham employees to gather detailed family health histories to give health care officials an edge fighting inherited diseases.

    2–4 minutes
  • Health

    Alternative screening could cut cervical cancer deaths in poor nations

    In the right hands, a swab of vinegar and a flashlight may detect more cervical cancer around the world than the recommended cytological screening known as a Pap smear. At the right time, a single DNA test for the virus that causes cervical cancer may also outperform repeated Pap smears.

    1–2 minutes
  • Health

    Low-dose chemotherapy plus antiangiogenesis drug has activity in advanced breast cancer

    Chemotherapy given in low, frequent doses – a novel strategy called “metronomic” delivery – achieved partial shrinkage of disease in some advanced breast cancer patients when given concurrently with an…

    1–2 minutes
  • Campus & Community

    Advances in stem cell biology presented at symposium

    Stem cell science is revolutionizing the field of cancer biology, changing the understanding of the structure of some tumors, and potentially shifting the treatment emphasis from eliminating all tumor cells…

    1–2 minutes
  • Campus & Community

    Cancer link to ‘protein promiscuity’ being studied

    When found at abnormally high concentrations, two proteins implicated in many human cancers have the potential to spur indiscriminate biochemical signaling inside cells, chemists at Harvard University have found. Their…

    1–2 minutes
  • Health

    Gingko may prevent ovarian cancer

    Researchers at Brigham and Women’s Hospital have found initial laboratory and epidemiological evidence that, for the first time, demonstrates that ginkgo may help lower a woman’s risk of developing ovarian…

    1–2 minutes
  • Health

    Herceptin treatment lowers recurrence rate in early breast cancer

    Encouraging findings came from an interim report from HERA, an ongoing large, international clinical trial of Herceptin, published Oct. 19, 2005 in the New England Journal of Medicine. The analysis…

    1–2 minutes
  • Health

    Double trouble: Cells with duplicate genomes can trigger tumors

    So-called “double-value” cells are produced by random errors in cell division that occur with unknown frequency. The generation of these genetically unstable cells appears to be a “pathway for generating…

    1–2 minutes
  • Health

    Subtle changes in normal genes implicated in breast cancer

    Scientists found that benign cells surrounding breast cancers undergo epigenetic modifications. The altered gene function causes the microenvironment cells to signal proliferation and increased aggression in the breast tumor cells.…

    1–2 minutes
  • Health

    Blood vessel drugs halt cancer growth

    After decades of surviving peer rejection of his theory of cancer treatment by blocking tiny blood vessels, Judah Folkman has gone on to develop drugs that did what he predicted…

    1–2 minutes